The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation
Launched by MEDICAL SCIENTIFIC FUND OF THE MAYOR OF VIENNA · Sep 6, 2012
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • female or male patients receiving peripheral bypass surgery
- • age between 55 and 75 years
- Exclusion Criteria:
- • metabolic acidosis
About Medical Scientific Fund Of The Mayor Of Vienna
The Medical Scientific Fund of the Mayor of Vienna is a prominent sponsor dedicated to advancing health research and medical innovation within the region. Established to support pioneering clinical trials and scientific studies, the Fund plays a critical role in fostering collaboration between academic institutions, healthcare providers, and industry stakeholders. By providing essential financial resources and strategic guidance, the Fund aims to enhance the quality of medical care, promote public health initiatives, and contribute to the development of novel therapeutic approaches, ultimately improving health outcomes for the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Jörg Michael Hiesmayr, Prof. Dr.
Study Director
Medical University of Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials